Tampa, Fla. — Although development of melanoma vaccines based on dendritic cells (DCs) lags behind that of more established approaches, it's rapidly moving from the lab bench into clinical trials.
Analyzing the Safety of JAK Inhibitors in Atopic Dermatitis Treatment
The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis
Botulinum Toxin Lacks Significant Effect in Seborrheic Dermatitis, Study Says
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Combination Surgery Plus Adalimumab More Clincially Effective in HS Than Adalimumab Alone
Expert Perspectives Into Empowering Patients With OTC Relief
2 Clarke Drive Cranbury, NJ 08512